Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report studies the global Colon & Rectal Carcinoma market status and forecast, categorizes the global Colon & Rectal Carcinoma market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
Colorectal cancer (CRC) is one of the “big four” tumor types, the third most common cancer to affect both men and women, and the third-leading cause of cancer-related death. The main differentiator between colon cancer and rectal cancer is the location of the primary tumor, but identical etiology and similar risk factors and symptoms mean that they are often grouped together.
The report details the trend, potential and market size of Colon & Rectal Carcinoma market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Colon & Rectal Carcinomamarket, defines the market attractiveness level of Colon & Rectal Carcinoma market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Colon & Rectal Carcinoma industry, describes the types of Colon & Rectal Carcinoma market, the applications of major players and the market size, and deeply analyzes the current situation of the global Colon & Rectal Carcinoma market and the development prospects and opportunities of Colon & Rectal Carcinoma industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Colon & Rectal Carcinoma market in Chapter 13.
By Player:
Pfizer
Novartis
Spectrum
Merck
Roche
Bayer Healthcare
Amgen
By Type:
Colon Carcinoma Treatment
Rectal Carcinoma Treatment
By End-User:
Hospital
Clinic
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Colon & Rectal Carcinoma Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Colon & Rectal Carcinoma Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Colon & Rectal Carcinoma Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Colon & Rectal Carcinoma Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Colon & Rectal Carcinoma Market Analysis and Outlook to 2022
-
7.1 Global Colon & Rectal Carcinoma Consumption (2017-2022)
-
7.2 United States Colon & Rectal Carcinoma Consumption (2017-2022)
-
7.3 Europe Colon & Rectal Carcinoma Consumption (2017-2022)
-
7.4 China Colon & Rectal Carcinoma Consumption (2017-2022)
-
7.5 Japan Colon & Rectal Carcinoma Consumption (2017-2022)
-
7.6 India Colon & Rectal Carcinoma Consumption (2017-2022)
-
7.7 South Korea Colon & Rectal Carcinoma Consumption (2017-2022)
8 Region and Country-wise Colon & Rectal Carcinoma Market Analysis and Outlook to 2028
-
8.1 Global Colon & Rectal Carcinoma Consumption Forecast (2022-2028)
-
8.2 United States Colon & Rectal Carcinoma Consumption Forecast (2022-2028)
-
8.3 Europe Colon & Rectal Carcinoma Consumption Forecast (2022-2028)
-
8.4 China Colon & Rectal Carcinoma Consumption Forecast (2022-2028)
-
8.5 Japan Colon & Rectal Carcinoma Consumption Forecast (2022-2028)
-
8.6 India Colon & Rectal Carcinoma Consumption Forecast (2022-2028)
-
8.7 South Korea Colon & Rectal Carcinoma Consumption Forecast (2022-2028)
9 Global Colon & Rectal Carcinoma Market Outlook by Types and Applications to 2022
-
9.1 Global Colon & Rectal Carcinoma Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Colon Carcinoma Treatment Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Rectal Carcinoma Treatment Consumption and Growth Rate (2017-2022)
-
9.2 Global Colon & Rectal Carcinoma Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
10 Global Colon & Rectal Carcinoma Market Outlook by Types and Applications to 2028
-
10.1 Global Colon & Rectal Carcinoma Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Colon Carcinoma Treatment Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Rectal Carcinoma Treatment Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Colon & Rectal Carcinoma Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
11 Global Colon & Rectal Carcinoma Import and Export Analysis (Top 5 Countries)
-
11.1 Global Colon & Rectal Carcinoma Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Colon & Rectal Carcinoma Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Colon & Rectal Carcinoma Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Colon & Rectal Carcinoma Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer Colon & Rectal Carcinoma Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Colon & Rectal Carcinoma Product and Service
-
14.2 Novartis
-
14.2.1 Novartis Company Details
-
14.2.2 Novartis Colon & Rectal Carcinoma Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Novartis Colon & Rectal Carcinoma Product and Service
-
14.3 Spectrum
-
14.3.1 Spectrum Company Details
-
14.3.2 Spectrum Colon & Rectal Carcinoma Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Spectrum Colon & Rectal Carcinoma Product and Service
-
14.4 Merck
-
14.4.1 Merck Company Details
-
14.4.2 Merck Colon & Rectal Carcinoma Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Merck Colon & Rectal Carcinoma Product and Service
-
14.5 Roche
-
14.5.1 Roche Company Details
-
14.5.2 Roche Colon & Rectal Carcinoma Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Roche Colon & Rectal Carcinoma Product and Service
-
14.6 Bayer Healthcare
-
14.6.1 Bayer Healthcare Company Details
-
14.6.2 Bayer Healthcare Colon & Rectal Carcinoma Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Bayer Healthcare Colon & Rectal Carcinoma Product and Service
-
14.7 Amgen
-
14.7.1 Amgen Company Details
-
14.7.2 Amgen Colon & Rectal Carcinoma Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Amgen Colon & Rectal Carcinoma Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Colon & Rectal Carcinoma
-
Figure Colon & Rectal Carcinoma Picture
-
Table Global Colon & Rectal Carcinoma Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Colon & Rectal Carcinoma Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Colon & Rectal Carcinoma Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Colon & Rectal Carcinoma Consumption by Country (2017-2022)
-
Figure United States Colon & Rectal Carcinoma Consumption and Growth Rate (2017-2022)
-
Table Europe Colon & Rectal Carcinoma Consumption and Growth Rate (2017-2022)
-
Figure China Colon & Rectal Carcinoma Consumption and Growth Rate (2017-2022)
-
Figure Japan Colon & Rectal Carcinoma Consumption and Growth Rate (2017-2022)
-
Figure India Colon & Rectal Carcinoma Consumption and Growth Rate (2017-2022)
-
Figure South Korea Colon & Rectal Carcinoma Consumption and Growth Rate (2017-2022)
-
Figure Global Colon & Rectal Carcinoma Consumption Forecast by Country (2022-2028)
-
Figure United States Colon & Rectal Carcinoma Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Colon & Rectal Carcinoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Colon & Rectal Carcinoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Colon & Rectal Carcinoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Colon & Rectal Carcinoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Colon & Rectal Carcinoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Colon Carcinoma Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Rectal Carcinoma Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Colon Carcinoma Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rectal Carcinoma Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Colon & Rectal Carcinoma Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Colon & Rectal Carcinoma Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Colon & Rectal Carcinoma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Colon & Rectal Carcinoma Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Colon & Rectal Carcinoma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Colon & Rectal Carcinoma Product and Service
-
Table Spectrum (Foundation Year, Company Profile and etc.)
-
Table Spectrum Colon & Rectal Carcinoma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Spectrum Colon & Rectal Carcinoma Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Colon & Rectal Carcinoma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Colon & Rectal Carcinoma Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Colon & Rectal Carcinoma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Colon & Rectal Carcinoma Product and Service
-
Table Bayer Healthcare (Foundation Year, Company Profile and etc.)
-
Table Bayer Healthcare Colon & Rectal Carcinoma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Healthcare Colon & Rectal Carcinoma Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Colon & Rectal Carcinoma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Colon & Rectal Carcinoma Product and Service
-
